Dana Farber Cancer Institute/Massachusetts General Hospital

Boston, Massachusetts 02215

0 studies enrolling now · 6 studies all time

What they study most

Acute Leukemia, Anemia, Sickle Cell, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia (CML), Hodgkin's Lymphoma, Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, MDS, Myelodysplasia

Studies at this site

• Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) — Completed
• TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) — Completed
• Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301) — Completed
• Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102) — Completed
• STRIDE Biorepository — Status unconfirmed
• Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) — Completed